Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. 4 Open-market buy 10% owner bought 4,686 shares at $5.10 ($23,899)
  2. 4 Open-market buy 10% owner bought 10,851 shares at an average $4.95 ($53,691)
  3. 4 Open-market sale Former 10% Owner sold 30,000 shares at $6.16 ($184,800)
  4. 4 Open-market buy 10% owner bought 329,153 shares at an average $4.93 ($1,624,121)
  5. 4 Open-market buy 10% owner bought 17,608 shares at an average $4.98 ($87,713)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3/A Insider 3/A
  20. 3 Insider Initial Statement of Ownership

Page 1 of 8 · 159 filings